NewsBenzingaAbbVie Raises FY2026 Adj EPS Guidance from $13.76-$13.96 to $13.95-$13.99 vs $13.93 Est AbbVie Raises FY2026 Adj EPS Guidance from $13.76-$13.96 to $13.95-$13.99 vs $13.93 Est Benzinga 2026.10.30 11:51 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3